Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 USD | 0.00% | -6.12% | -0.54% |
Apr. 12 | Transcript : Cognition Therapeutics, Inc. - Special Call | |
Mar. 26 | Transcript : Cognition Therapeutics, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 71.76M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -64M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.89
x | P/E ratio 2025 * |
-1.32
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.78% |
Latest transcript on Cognition Therapeutics, Inc.
1 week | -6.12% | ||
Current month | +1.10% | ||
1 month | +0.55% | ||
3 months | -20.00% | ||
6 months | +44.88% | ||
Current year | -0.54% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
John Doyle
DFI | Director of Finance/CFO | 46 | 23-04-30 |
Paul J. Tiseo
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
Brett Monia
BRD | Director/Board Member | 62 | 20-09-30 |
Ellen Richstone
BRD | Director/Board Member | 72 | 21-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1.84 | 0.00% | 116,803 |
24-04-18 | 1.84 | -3.16% | 100,125 |
24-04-17 | 1.9 | +0.53% | 75,924 |
24-04-16 | 1.89 | -1.05% | 121,960 |
24-04-15 | 1.91 | -2.55% | 62,065 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.54% | 71.76M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- CGTX Stock